Browse Studies — Arctuva

Phase 1

(2R,6R)-Hydroxynorketamine a Novel Therapeutic Analgesic for the Treatment of Neuropathic Pain: A Randomized Double Blind Cross-Over Trial.

The goal of this randomized double blind three way (1:1:1) cross over clinical trial is to evaluate the effectiveness and duration of analgesia of a single inf…

Pain, Neuropathic

Estimated

~$10 – $6,250

Rush University Medical CenterNCT05864053

Observational

Novel Stimulation Patterns to Improve the Effectiveness of Spinal Cord Stimulation

The goal of this study is to compare pain outcomes achieved by spinal cord stimulation (SCS) using time varying stimulation patterns with pain outcomes achieve…

Chronic PainPain, NeuropathicNeuropathic Pain

Estimated

~$10 – $7,500

Ashwin ViswanathanNCT05968664

Observational

Scrambler Therapy for Corticobasal Syndrome-Associated Pain

The goal of this pilot trial is to test whether scrambler therapy (ST) is an effective treatment for neuropathic pain in patients with corticobasal syndrome (C…

Corticobasal DegenerationCorticobasal SyndromePain, Neuropathic

Estimated

~$10 – $6,250

Johns Hopkins UniversityNCT05653778

Observational

Surgical Treatments for Postamputation Pain

This is a double-blind randomised controlled trial (RCT) which compares the effectiveness of three surgical techniques for alleviating residual limb pain (RLP)…

Residual Limb PainAmputation NeuromaPhantom Limb Pain+2 more

Estimated

~$10 – $7,500

Prometei Pain Rehabilitation CenterNCT05009394